Calidi Biotherapeutics, Inc.
CLDI
$1.56
-$0.18-10.35%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.28M | 10.56M | 9.59M | 1.90M | 836.00K |
| Total Receivables | 50.00K | 50.00K | -- | -- | 181.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 377.00K | 596.00K | 536.00K | 108.00K | 402.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 343.00K | 282.00K | 100.00K | 216.00K | 206.00K |
| Total Current Assets | 6.05M | 11.49M | 10.23M | 2.22M | 1.63M |
|
|
|||||
| Total Current Assets | 6.05M | 11.49M | 10.23M | 2.22M | 1.63M |
| Net Property, Plant & Equipment | 3.26M | 3.43M | 3.80M | 4.22M | 4.58M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 40.00K | 144.00K | 152.00K | 217.00K | 227.00K |
| Total Assets | 9.35M | 15.06M | 14.18M | 6.66M | 6.43M |
|
|
|||||
| Total Accounts Payable | 1.23M | 1.21M | 2.07M | 3.57M | 4.55M |
| Total Accrued Expenses | 1.93M | 1.77M | 2.98M | 3.58M | 4.14M |
| Short-term Debt | -- | -- | 474.00K | 459.00K | 444.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.19M | 2.45M | 3.97M | 3.86M | 3.72M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 100.00K | 200.00K |
| Total Other Current Liabilities | -- | -- | -- | 100.00K | 200.00K |
| Total Current Liabilities | 5.35M | 5.43M | 9.50M | 11.58M | 13.05M |
|
|
|||||
| Total Current Liabilities | 5.35M | 5.43M | 9.50M | 11.58M | 13.05M |
| Long-Term Debt | 600.00K | 600.00K | 600.00K | 2.37M | 1.93M |
| Short-term Debt | -- | -- | 474.00K | 459.00K | 444.00K |
| Capital Leases | 1.22M | 1.65M | 1.99M | 2.33M | 2.64M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 103.00K | 87.00K | 128.00K | 176.00K | 565.00K |
| Total Liabilities | 7.28M | 7.77M | 12.21M | 16.46M | 18.18M |
|
|
|||||
| Common Stock & APIC | 134.19M | 133.67M | 123.28M | 107.41M | 100.84M |
| Retained Earnings | -132.42M | -126.70M | -121.72M | -117.62M | -112.56M |
| Treasury Stock & Other | -13.00K | -26.00K | -28.00K | -74.00K | -27.00K |
| Total Common Equity | 1.76M | 6.94M | 1.53M | -10.28M | -11.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.76M | 6.94M | 1.53M | -10.28M | -11.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 312.00K | 358.00K | 434.00K | 485.00K | -- |
| Total Equity | 2.08M | 7.30M | 1.97M | -9.80M | -11.75M |
|
|
|||||